What Was The Reason Behind BioLineRx (BLRX) Stock Increasing 8% In Extended Session?

The pre-commercial stage biopharmaceutical business BioLineRx Ltd. (NASD: BLRX) has increased 8.35% at $0.75 in after-hours trading hours on the latest check Friday after providing a corporate and portfolio update. What kind of update has BLRX given? When presenting its financial results this month, BioLineRx (BLRX) also gave business and portfolio updates. The conclusion of […]

Frisco Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.